OPTIC NERVE DISEASE

Clinical trials for OPTIC NERVE DISEASE explained in plain language.

Never miss a new study

Get alerted when new OPTIC NERVE DISEASE trials appear

Sign up with your email to follow new studies for OPTIC NERVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Vitamin B3 tested as potential lifeline for sudden vision loss

Disease control Not yet recruiting

This study is testing whether a high daily dose of nicotinamide (Vitamin B3) can help preserve or improve vision in people with Leber's hereditary optic neuropathy (LHON), a rare genetic disease that causes sudden, severe vision loss. It will enroll 13 people who developed LHON s…

Matched conditions: OPTIC NERVE DISEASE

Phase: PHASE1 • Sponsor: University Hospital, Angers • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

OPTIC NERVE DISEASE

Get alerted when new OPTIC NERVE DISEASE trials appear

Vitamin B3 tested as potential lifeline for sudden vision loss